Friday, January 29, 2010

Medical News

Medical News


Intravenous opioid users at risk for DVT

Posted: 28 Jan 2010 04:00 PM PST

Intravenous drug use is a significant risk factor for deep vein thrombosis, Iranian researchers suggest after studying a group of opiate addicts.

No increased cancer risk with coal tar treatment

Posted: 28 Jan 2010 04:00 PM PST

Researchers say that coal tar for the treatment of psoriasis and eczema should not be abandoned, after finding concerns of an associated increased risk for cancer are unfounded.

Prostate cancer treatment choice depends on ethnicity

Posted: 28 Jan 2010 04:00 PM PST

The choice of primary therapy among prostate cancer patients differs significantly between African–American and White men, study findings show.

Starting penile rehabilitation early improves erectile function recovery after RP

Posted: 28 Jan 2010 04:00 PM PST

Men who delay the start of penile rehabilitation after radical prostatectomy for prostate cancer do not recover erectile function as well as men who begin rehabilitation immediately, report US researchers.

Prostate cancer treatment choice depends on ethnicity

Posted: 28 Jan 2010 04:00 PM PST

The choice of primary therapy among prostate cancer patients differs significantly between African–American and White men, study findings show.

Traztuzumab improves outcome of HER2-positive locally advanced or inflammatory breast cancer

Posted: 28 Jan 2010 04:00 PM PST

Neoadjuvant trastuzumab should be offered to patients with human epidermal growth factor receptor 2­positive locally advanced or inflammatory breast cancer alongside neoadjuvant chemotherapy, researchers report in The Lancet.

Starting penile rehabilitation early improves erectile function recovery after RP

Posted: 28 Jan 2010 04:00 PM PST

Men who delay the start of penile rehabilitation after radical prostatectomy for prostate cancer do not recover erectile function as well as men who begin rehabilitation immediately, report US researchers.

Fatty acids combination preferable for determining CVD risk

Posted: 28 Jan 2010 04:00 PM PST

Fatty acids may be better at determining the risk for cardiovascular disease when assessed in combination rather than individually, researchers suggest.

ACE inhibitors inhibit foam-cell formation through MMP-9 inhibition

Posted: 28 Jan 2010 04:00 PM PST

ACE inhibitors may reduce foam-cell formation triggered by oxidized low-density lipoprotein by affecting the activity of matrix metalloproteinase-9, research suggests.

Repeat self-measures of blood glucose mirror glycemic control

Posted: 28 Jan 2010 04:00 PM PST

Self-monitored blood glucose measurements are moderately well-correlated with glycated hemoglobin values in patients with Type 2 diabetes mellitus, study results show.

Macrovascular complications in diabetes tied to greater resource use

Posted: 28 Jan 2010 04:00 PM PST

Use of healthcare resources by patients with diabetes is greater among those with comorbid macrovascular complications, a pan-European survey has found.

Home based as effective as hospital based cardiac rehabilitation

Posted: 28 Jan 2010 04:00 PM PST

Home and center based forms of cardiac rehabilitation seem to be equally effective in improving clinical and health-related quality of life outcomes in patients with a low-risk for further events after myocardial infarction or revascularization, conclude researchers.

Preoperative stress testing improves non-cardiac surgery outcomes in high-risk patients

Posted: 28 Jan 2010 04:00 PM PST

Preoperative noninvasive cardiac stress testing is associated with improved 1-year survival and reduced hospital stay in patients undergoing elective non-cardiac surgery who are at high risk for cardiac complications, a large population-based study has found.

Traztuzumab improves outcome of HER2-positive locally advanced or inflammatory breast cancer

Posted: 28 Jan 2010 04:00 PM PST

Neoadjuvant trastuzumab should be offered to patients with human epidermal growth factor receptor 2­positive locally advanced or inflammatory breast cancer alongside neoadjuvant chemotherapy, researchers report in The Lancet.

No comments:

Post a Comment